BMT Publications

2009

Varadarajan P, Dunford LM, Thomas JA, Brown K, Paplham P, Syta M, Schiff M, Padmanabhan S, Battiwalla M, Smiley S, Hahn T, McCarthy PL. Gastric hypomotility accompanying colonic hypermotility: Delayed gastric transit time as a prominent complication of GI GvHD revealed during wireless capsule endoscopy visualization of small bowel pathology. Biol Blood Marrow Transplant 15:643-8, 2009.  PMID: 19361758
 
Hahn T, Yao S, Dunford L, Thomas J, Lohr J, Arora P, Battiwalla M, Smiley S, McCarthy PL. A comparison of measured creatinine clearance vs. calculated glomerular filtration rate for the assessment of renal function before autologous or allogeneic BMT. Biol Blood Marrow Transplant 15:574-9, 2009. PMID: 19361749
 
Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL, Hahn T.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review. Biol Blood Marrow Transplant 15:137-172, 2009. PMID: 19167676
 

With accompanying editorial: LeMaistre CF. Defining Medicare coverage for MDS treatment and research: A time for action? Biol Blood Marrow Transplant 15:133-134, 2009

2008

Ringden O, Pavletic S, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Giralt S, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, McCarthy PL, Cowan MJ, Petersdorf EW, Russel JA, Schiller GJ, Schouten H, Tallman MS, Verdonck LF, Wiley JM, Wingard JR, Horowitz MM, Arora M.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113:3110-8, 2009. EPub ahead of print Dec 4, 2008.  PMID: 19059878
 
Hahn T*,  McCarthy PL*, Zhang MZ, Wang D, Arora M, Sobocinski K, Frangoul H, Gale RP, Hale G, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Verdonck LF, Bolwell B, Bredeson C, Chen A, Holler E, Litzow M, Russell J, Pavletic S, Barrett AJ, Ringdén O. Risk factors for grade II-IV acute graft-versus-host disease after HLA-identical sibling transplants for adults with leukemia. *First two authors contributed equally. J Clin Oncol 26:5728-34, 2008.  EPub ahead of print Nov 3, 2008.  
 
Aggarwal C, Gupta S, Hahn T, Smiley S, Padmanabhan S, McCarthy PL, Battiwalla M. Human Leukocyte Antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies. Leuk Lymphoma 2008 (in press).
 
Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 14:137-180, 2008
 
Benekli M, Smiley SL, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, Battiwalla M, Padmanabhan S, McCarthy PL, Hahn T. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide, and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin Disease: high likelihood of cure at 2 years. Bone Marrow Transplant 41:613-619, 2008. EPub ahead of print Dec 10, 2007.